Sleep Health Opportunity StimScience focuses on commercializing neuroscience and sleep research into products for individuals, employers, and health plans, signaling a clear market fit for workplace wellness programs and sleep improvement initiatives.

Clinical Credibility With world-renowned scientists and advisors and backing from Khosla Ventures, StimScience has strong credibility to engage hospitals, clinics, and health plans seeking evidence-based sleep interventions.

Somnee Product Launch Somnee, their advanced diagnostic and therapeutic sleep product launched in 2022, presents a tangible entry point for B2C and B2B partnerships, including employer wellness programs and direct-to-consumer channels.

Strategic Partnerships Past seed funding and notable team members from Fitbit, Google, and Samsung suggest potential collaboration avenues with tech manufacturers, wearable companies, and consumer electronics retailers.

Growth Ambition Despite early revenue under one million, StimScience has a clear growth trajectory and a total funding of ten million, indicating readiness to scale through enterprise deals, licensing, and managed services for sleep health.